NEXGEL, INC. (NXGL) research

NEXGEL, INC.

Sector: Healthcare
Industry: Medical Instruments & Supplies
Last price: $0.17
As of: 2026-10-02

NEXGEL, INC. (NXGL): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-24.

As of 2026-09-24, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for NXGL. Method and limitations.

COMPANY DOSSIER

See the full NXGL dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for NXGL on one page. Preview it with sample data, then open it live with a free account.

Preview the NXGL dossier

Active signals for NXGL

mediumEARNINGS_MISS2026-09-06
Q2-2026: Missed consensus by 202.3%, EPS $-0.37 vs $-0.1224 estimate
All 2026-09-06 signals →
mediumEARNINGS_MISS2026-06-19
Q2-2025: Missed consensus by 26.1% - EPS $-0.09 vs $-0.0714 estimate
All 2026-06-19 signals →
mediumEARNINGS_MISS2026-05-31
Q1-2026: Missed consensus by 26.1% - EPS $-0.09 vs $-0.0714 estimate
All 2026-05-31 signals →
mediumEARNINGS_MISS2026-05-31
Q4-2025: Missed consensus by 30.7% - EPS $-0.12 vs $-0.0918 estimate
All 2026-05-31 signals →
mediumEARNINGS_MISS2026-05-31
Q1-2026: Missed consensus by 54.1% - EPS $-0.11 vs $-0.0714 estimate
All 2026-05-31 signals →

FREE, NO ACCOUNT

Every signal on NXGL, as it fires

New filings, 13F moves and cross asset signals on NXGL land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in NXGL (2026Q2)

Manager / security	Market value	% portfolio	QoQ
CITADEL ADVISORS LLCCUSIP 65344E107 · 2026Q2	$21K	0.00%	,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, NXGL

8-K2026-09-24
SEC EDGAR ↗
8-K2026-09-23
SEC EDGAR ↗
8-K2026-08-21
SEC EDGAR ↗
10-Q2026-08-17
SEC EDGAR ↗
8-K2026-08-17
SEC EDGAR ↗
8-K2026-08-05
SEC EDGAR ↗
8-K2026-07-29
SEC EDGAR ↗
8-K2026-07-09
SEC EDGAR ↗
8-K2026-07-02
SEC EDGAR ↗
8-K2026-06-17
SEC EDGAR ↗

NXGL against its peers

NXGL's operating margin of -29.3% ranks in the 59th percentile of 15 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.

Metric	NXGL	Peer median	Percentile	n
Revenue FY	11.4M USD	24.6M USD	38	16
Revenue YoY	n/a	65.2%	n/a	5
Gross margin	39.5%	42.1%	50	14
Operating margin	-29.3%	-56.1%	59	15
Net margin	-26.3%	-64.6%	62	16
Return on equity	-67.3%	-71.6%	50	18

Peers (20): GCTK, YBGJ, MHUAF, LUCY, UEEC, RGNT, CUPR, BNGO, FEMY, RVP, HBIO, MLSS, NEPH, POCI, MBOT, STXS, KRMD, NYXH, ZJYL, PDEX. Left out: TUTH (no annual filing), ECIA (period gap), RSCF (period gap), ZTEK (no annual filing), DXR (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (NXGL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more NXGL signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NXGLand get the insider, 13F, options, and confluence read in one view.